Sorafenib for Patients with Hepatocellular Carcinoma and Child‐Pugh B Liver Cirrhosis: Lessons Learned from a Terminated Study

LESSONS LEARNED: Recruitment of patients with advanced hepatocellular carcinoma and Child‐Pugh B for sorafenib treatment and additional pharmacokinetic studies is challenging. Patients with Child‐Pugh B liver cirrhosis have high rates of cirrhosis‐related adverse events. BACKGROUND: Few data are ava...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncologist
Hoofdauteurs: Labeur, Tim A., Achterbergh, Roos, Takkenberg, Bart, Van Delden, Otto, Mathôt, Ron, Klümpen, Heinz‐Josef
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley & Sons, Inc. 2019
Onderwerpen:
Clinical Trial Results
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485346/
https://ncbi.nlm.nih.gov/pubmed/31645371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0718
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items